Intero Biosystems Advances Human Intestinal Organoids for Drug Testing Alternatives

Intero Biosystems develops human intestinal organoids as a more accurate alternative to animal testing for drug development, with its GastroScreen product enabling drug safety and disease research. Regulatory shifts toward non-animal testing methods, including FDA guidance, are accelerating adoption of such technologies.

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

Read original article